Publicación:
SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes

dc.contributor.authorGaray Montalvo, Evelin
dc.contributor.authorSerrano Coll, Héctor Alejandro
dc.contributor.authorRivero, Ricardo
dc.contributor.authorGastelbondo Pastrana, Bertha Irina
dc.contributor.authorFaccini Martínez, Álvaro Adolfo
dc.contributor.authorBerrocal, José
dc.contributor.authorPérez, Alejandra
dc.contributor.authorBadillo, María
dc.contributor.authorMartínez Bravo, Caty Milena
dc.contributor.authorBotero, Yesica
dc.contributor.authorArrieta Bernate, Germán Javier
dc.contributor.authorCalderón Rangel, Alfonso
dc.contributor.authorGaleano Anaya, Ketty Esther
dc.contributor.authorLópez Mejía, Yesica Paola
dc.contributor.authorMiranda Regino, Jorge Luis
dc.contributor.authorGuzmán Terán, Camilo Antonio
dc.contributor.authorContreras Cogollo, Veronica
dc.contributor.authorArosemena, Alejandra
dc.contributor.authorContreras, Héctor
dc.contributor.authorBrango Tarra, Eimi Johana
dc.contributor.authorOviedo Pastrana, Misael Enrique
dc.contributor.authorMattar Velilla, Ameth Salim
dc.contributor.corporatenameCorporación Universitaria del caribe - CECAR
dc.contributor.researchgroupSalud Pública y Auditoría en Salud
dc.date.accessioned2025-08-28T15:41:01Z
dc.date.issued2021
dc.description.abstractBackground: Serological evaluation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an alternative that allows us to determine the prevalence and dynamics of this infection in populations. The goal of this study was to determine the clinical and sociodemographic dynamics of SARS-CoV-2 infection in a region of the Colombian Caribbean. Methods: Between July and November 2020, a cross-sectional observational study was carried out in Córdoba, located in northeast Colombia in the Caribbean area. Eight municipalities with the largest populations were chosen and 2564 blood samples were taken. A commercial enzyme-linked immunosorbent assay was used with the recombinant protein antigen N of SARS-CoV-2. The people included in the study were asked for sociodemographic and clinical data, which were analysed by statistical methods. Results: A seroprevalence of 40.8% was obtained for SARS-CoV-2 in the Córdoba region. In the bivariate analysis, no differences were observed in seropositivity against SARS-CoV-2 for gender or age range (p>0.05). Higher seropositivity was found in low socio-economic status and symptomatic patients (p<0.0001). A total of 30.7% of the asymptomatic patients were seropositive for SARS-CoV-2, which could be linked to the spread of this infection. In the multivariate analysis, seroconversion was related to poverty and clinical manifestations such as anosmia and ageusia (p<0.05). Conclusions: The high seropositivity in Córdoba is due to widespread SARS-CoV-2 in this population. The relationship between seropositivity and socio-economic status suggests a higher exposure risk to the virus caused by informal economic activities in low-income groups. Clinical manifestations such as anosmia and ageusia could be clinical predictors of infection by the new emergent coronavirus.
dc.description.researchareaAuditoría en Salud
dc.description.researchareaSalud Pública
dc.format.extent9 páginas
dc.format.mimetypeapplication/pdf
dc.identifier.eissn1878-3503
dc.identifier.urihttps://repositorio.cecar.edu.co/handle/cecar/10786
dc.language.isoeng
dc.publisher.placeColombia
dc.relation.citationendpage147
dc.relation.citationstartpage139
dc.relation.ispartofjournalTransactions Royal Society of Tropical Medicine and Hygiene
dc.relation.referencesReina J. El SARS-CoV-2, una nueva zoonosis pandémica que amenaza al mundo. Vacunas. 2020;21(1):17–22.
dc.relation.referencesNoor AU, Maqbool F, Bhatti ZA, et al. Epidemiology of CoViD-19 pandemic: recovery and mortality ratio around the globe. Pak J Med Sci. 2020;36(COVID-19-S4):S79–84.
dc.relation.referencesGuo Y-R, Cao Q-D, Hong Z-S, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak—an update on the status. Mil Med Res. 2020;7(1):1–10.
dc.relation.referencesCapobianco G, Saderi L, Aliberti S, et al. COVID-19 in pregnant women: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;252:543–58.
dc.relation.referencesWorld Health Organization. WHO coronavirus disease (COVID-19) dashboard. Available from: https://covid19.who.int/ [accessed 3 March 2021].
dc.relation.referencesMinisterio de Salud y Protección Social. Coronavirus (COVID-19). Reportes y Tableros de Control. Available from: https://www.minsalud. gov.co/salud/publica/PET/Paginas/Covid-19_copia.aspx [accessed 18 May 2021].
dc.relation.referencesNikolai LA, Meyer CG, Kremsner PG, et al. Asymptomatic SARS coronavirus 2 infection: invisible yet invincible. Int J Infect Dis. 2020;100:112–6.
dc.relation.referencesPercivalle E, Cambiè G, Cassaniti I, et al. Prevalence of SARSCoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020. Eurosurveillance. 2020;25(24):2001031.
dc.relation.referencesNoh JY, Bin SY, Yoon JG, et al. Seroprevalence of anti-SARS-CoV-2 antibodies among outpatients in southwestern Seoul, Korea. J Korean Med Sci. 2020;35(33):e311.
dc.relation.referencesMattar S, Alvis-Guzman N, Garay E, et al. Severe acute respiratory syndrome coronavirus 2 seroprevalence among adults in a tropical city of the Caribbean area, Colombia: are we much closer to herd immunity than developed countries? Open Forum Infect Dis. 2020;7(12):ofaa550.
dc.relation.referencesEurofins. INgezim COVID 19 DR. Available from: https://ingenasa. eurofins-technologies.com/home-es/productos/covid19/ensayoelisa/ingezim-covid-19-dr/ [accessed 16 June 2021].
dc.relation.referencesFranco R, Hopenhayn M, León A. The growing and changing middle class in Latin America: an update. Cepal Rev. 2011.
dc.relation.referencesDodd RY, Xu M, Stramer SL. Change in donor characteristics and antibodies to SARS-CoV-2 in donated blood in the US, June–August 2020. JAMA. 2020;324(16):1677–9.
dc.relation.referencesReyes-Vega MF, Soto-Cabezas MG, Cárdenas F, et al. SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: a population-based seroepidemiological survey in Lima, Peru. EClinicalMedicine 2021;34: 100801.
dc.relation.referencesXu X, Sun J, Nie S, et al. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nat Med. 2020;26(8): 1193–5.
dc.relation.referencesBuss LF, Prete CA, Jr, Abrahim CMM, et al. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science. 2021;371(6526):288–92.
dc.relation.referencesFaccini-Martínez ÁA, Rivero R, Garay E, et al. Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection, Colombia. Int J Infect Dis. 2020;101:191–3.
dc.relation.referencesSwedish Public Health Agency. Initial results from ongoing investigation of antibodies to covid-19 virus. Available from: https://www. folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2020/maj/ forsta-resultaten-fran-pagaende-undersokning-av-antikroppar-forcovid-19-virus/ [accessed 16 June 2021].
dc.relation.referencesStringhini S, Wisniak A, Piumatti G, et al. Seroprevalence of antiSARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396(10247):313–9.
dc.relation.referencesBunders MJ, Altfeld M. Implications of sex differences in immunity for SARS-CoV-2 pathogenesis and design of therapeutic interventions. Immunity. 2020;53(3):487–95.
dc.relation.referencesFigar S, Pagotto V, Luna L, et al. Community-level SARS-CoV-2 seroprevalence survey in urban slum dwellers of Buenos Aires City, Argentina: a participatory research. medRxiv. 2020; doi: 10.1101/2020.07.14.20153858.
dc.relation.referencesMattar S, Martinez-Bravo C, Rivero R, et al. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean. Ann Clin Microbiol Antimicrob. 2020;19(1):58.
dc.relation.referencesBampoe S, Lucas DN, Neall G, et al. A cross-sectional study of immune seroconversion to SARS-CoV-2 in frontline maternity health professionals. Anaesthesia. 2020;75(12):1614–9.
dc.relation.referencesPaolo C, Carmelo S, Marcello M. Ageusia, gastrointestinal symptoms and marked asthenia in late December. A single case report with positive SARS-Cov2 IgG in Italy. Int J Infect Dis. 2020;97: 352–3.
dc.relation.referencesLechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-tomoderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8): 2251–61.
dc.relation.referencesEuropean Centre for Disease Prevention and Control. Rapid risk assessment: risk of COVID-19 transmission related to the end-of-year festive season. Available from: https://www.ecdc.europa.eu/en/publicationsdata/risk-assessment-covid-19-festive-season. [ accessed 16 June 2021].
dc.rightsDerechos reservados - Corporación Universitaria de Caribe - CECAR
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2
dc.rights.licenseAtribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.sourcehttps://doi.org/10.1093/trstmh/trab094 A
dc.subject.proposalAsymptomatic infections
dc.subject.proposalEconomic conditions
dc.subject.proposalInformal social controls
dc.subject.proposalPublic health
dc.subject.proposalSeroepidemiologic studies
dc.subject.proposalSocial conditions
dc.titleSARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomeseng
dc.typeArtículo de revista
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.contentText
dc.type.driverinfo:eu-repo/semantics/article
dc.type.redcolhttp://purl.org/redcol/resource_type/ART
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
ARS-CoV-2 in eight municipalities of the Colombian tropics.pdf
Tamaño:
838.93 KB
Formato:
Adobe Portable Document Format

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
14.49 KB
Formato:
Item-specific license agreed upon to submission
Descripción: